Adalimumab plus methotrexate is more effective than adalimumab alone in patients with rheumatoid arthritis (RA) - Results from a longitudinal observational study

被引:0
|
作者
Schrumpf, M
Rodevand, E
Mikkelsen, K
Kaufmann, C
Didriksen, A
Mowinckel, P
Kvien, TK
机构
[1] Diakonhjemmet Sykehus, Dept Rheumatol, Oslo, Norway
[2] St Olav Hosp, Dept Rheumatol, Trondheim, Norway
[3] Lillehammer Hosp Rheumat Dis, Dept Rheumatol, Lillehammer, Norway
[4] Univ Hosp No Norway, Tromso, Norway
[5] Buskerud Cent Hosp, Drammen, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:184 / +
页数:2
相关论文
共 50 条
  • [31] Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial
    Sode, Jacob
    Krintel, Sophine B.
    Carlsen, Anting Liu
    Hetland, Merete L.
    Johansen, Julia S.
    Horsley-Petersen, Kim
    Stengaard-Pedersen, Kristian
    Ellingsen, Torkell
    Burton, Mark
    Junker, Peter
    Ostergaard, Mikkel
    Heegaard, Niels H. H.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (01) : 53 - 61
  • [32] Adalimumab plus methotrexate improves work stability and reduces job loss in early rheumatoid arthritis (RA): Results of the pevention of work disability (PROWD) study.
    Bejarano, Victoria
    Quinn, Mark
    Conaghan, Philip G.
    Keenan, Anne-Maree
    Reece, Richard J.
    Walker, David
    Gough, Andrew K.
    Emery, Paul
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4037 - 4038
  • [33] Adalimumab In Combination With High and Low Dose-Methotrexate In Rheumatoid Arthritis Patients With Inadequate Response To Methotrexate: Pharmacokinetic Results From The Musica Study
    Ahmed, Ghada
    Goss, Sandra L.
    Klein, Cheri E.
    Mozaffarian, Neelufar
    Kaeley, Gurjit S.
    Awni, Walid
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S623 - S624
  • [34] Two-year results of realise-a postmarketing observational study:: Effectiveness and safety of adalimumab (humira®) is maintained in patients with rheumatoid arthritis (ra)
    Burmester, G. R.
    Cerinic, M. Matucci
    Mariette, X.
    Blasco, F. Navarro
    Oezer, U.
    Jaeger, M.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 165 - 165
  • [35] Health economic evaluation of patients with rheumatoid arthritis (RA) treated with adalimumab
    Vanoverbeke, N
    Annemans, L
    Cauchie, P
    Hendrickx, E
    VALUE IN HEALTH, 2004, 7 (06) : 663 - 663
  • [36] Response to adalimumab in patients with early versus late rheumatoid arthritis (RA)
    Keystone, E
    Kavanaugh, A
    Fischkoff, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 170 - 170
  • [37] Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses
    Nakashima, Yasuharu
    Miyahara, Hisaaki
    Kondo, Masakazu
    Fukuda, Takaaki
    Harada, Hiroshi
    Haraguchi, Akihisa
    Inoue, Yasushi
    Ishinishi, Takashi
    Maekawa, Masayuki
    Maeyama, Akira
    Nakashima, Munetoshi
    Shono, Eisuke
    Suematsu, Eiichi
    Shimauchi, Takashi
    Tsuru, Tomomi
    Tsukamoto, Hiroshi
    Yoshizawa, Shigeru
    Yoshizawa, Seiji
    Iwamoto, Yukihide
    MODERN RHEUMATOLOGY, 2017, 27 (01) : 15 - 21
  • [38] Induction of long-term remission in patients with rheumatoid arthritis treated with adalimumab (humira®) plus methotrexate
    Schiff, MH
    Weisman, MH
    Furst, DE
    Kavanaugh, A
    Spencer-Green, GT
    Szczerbak, NA
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 297 - 297
  • [40] Identification of Genetic Variants Associated with Response to Adalimumab Plus Methotrexate in Patients with Early Rheumatoid Arthritis.
    Skapenko, Alla
    Schulze-Koops, Hendrik
    Devanarayan, Viswanath
    Idler, Kenneth
    Hong, Feng
    Smolen, Josef S.
    Kavanaugh, Arthur
    Kupper, Hartmut
    Waring, Jeffrey F.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S497 - S497